PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
Global IoT Security Market will reach USD 464 Million by 2020
May 31, 2017 13:34 pm UTC| Business
Deerfield Beach, FL, May 31, 2017 -- Zion Market Research has published a new report titled “IoT Security Market for Utilities, Automotive, Healthcare and Other End-users: Global Industry Perspective, Comprehensive...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:35 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
May 31, 2017 13:34 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...